137 related articles for article (PubMed ID: 2110909)
1. Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha.
Takahashi M; Oshimi K; Mizoguchi H
Exp Hematol; 1990 Jun; 18(5):395-9. PubMed ID: 2110909
[TBL] [Abstract][Full Text] [Related]
2. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
3. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro.
Zucali JR; Broxmeyer HE; Gross MA; Dinarello CA
J Immunol; 1988 Feb; 140(3):840-4. PubMed ID: 3276782
[TBL] [Abstract][Full Text] [Related]
5. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
Pak AS; Ip G; Wright MA; Young MR
Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of suppression of normal hemopoietic activity by lymphokine-activated killer cells and their products.
Gibson FM; Malkovska V; Myint AA; Meager A; Gordon-Smith EC
Exp Hematol; 1991 Aug; 19(7):659-63. PubMed ID: 1909968
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.
Wang CQ; Udupa KB; Lipschitz DA
J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
9. The influence of the supernatant obtained from a culture of IL-2-activated lymphocytes on human hematopoietic progenitors.
Iizuka Y; Endo M; Horikoshi A; Takeuchi J; Ohshima T
Exp Hematol; 1990 Feb; 18(2):119-23. PubMed ID: 1689247
[TBL] [Abstract][Full Text] [Related]
10. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
Platzer E; Rubin BY; Lu L; Welte K; Broxmeyer HE; Moore MA
J Immunol; 1985 Jan; 134(1):265-71. PubMed ID: 3917276
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
Murphy M; Perussia B; Trinchieri G
Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
13. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
[TBL] [Abstract][Full Text] [Related]
14. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2.
Burdach S; Shatsky M; Wagenhorst B; Levitt L
J Immunol; 1987 Jul; 139(2):452-8. PubMed ID: 3110272
[TBL] [Abstract][Full Text] [Related]
15. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
Broxmeyer HE; Cooper S; Rubin BY; Taylor MW
J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE
J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor.
Pelus LM; Ottmann OG; Nocka KH
J Immunol; 1988 Jan; 140(2):479-84. PubMed ID: 3121745
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation.
Naldini A; Fleischmann WR; Ballas ZK; Klimpel KD; Klimpel GR
J Immunol; 1987 Sep; 139(6):1880-4. PubMed ID: 2442258
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
[TBL] [Abstract][Full Text] [Related]
20. Monocytes enhance gamma-interferon-induced inhibition of myeloid progenitor cell growth through secretion of tumor necrosis factor.
Cannistra SA; Groshek P; Griffin JD
Exp Hematol; 1988 Nov; 16(10):865-70. PubMed ID: 3139436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
